More assertive...April 2018, Financial PressRelease...Genenews said (Quote) Test volume was essencially '' Flat '' (End of Quote).
May 2018, Financial PressRelease... Genenews said (Quote) Test volume is '' Expected '' to grow (End of Quote).
All of a sudden in Aug 2018 Financial PressRelease the wording has become more assertive.
Genenews said (Quote) Q3 has started with a bang in July with test volume up 40%, cash receips from our billing early in Q3 showing the increases we have been expecting, and incremental(increase) testing with high risk population, as well as the AIM reps beginning (End of Quote).
First time in the last few years that Genenews has positive grow in tests volume.
In Aug 2018 AIM Laboratories big distribution network has started to sell Genenews multiple cancer tests.
In Aug & Sept 2018 we should see an even bigger grow in test volume (over 40%).
These 3 months consecutive grow in tests volume will appear in the next financial.
The assertive wording in the last financial indicate that Genenews is getting closer and closer to that very first green positive financial report.
Never underestimate the impact of the first time green profit in a pharmaceutical company, even a very small green profit will wake-up the market to the huge potential of Genenews innovative cancer tests.